Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Gemneo Bioscience

2016 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$100K LATEST DEAL AMOUNT
Description

Developer of an immune cell profiling technology designed to provide more optimal cancer treatments and groundbreaking immunotherapies to help improve cancer outcomes. The company's cell profiling technology identifies each patient's unique tumor signature and suggests key immune elements to exploit during immunotherapy, enabling physicians to better understand and tailor treatments around individual patient's disease and immune responses.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare
Primary Office
  • 1475 North Scottsdale Road
  • Suite 200
  • Scottsdale, AZ 85257
  • United States

+1 (775) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Gemneo Bioscience’s full profile, request a free trial.

Gemneo Bioscience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 25-Oct-2017 $100K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Gemneo Bioscience Executive Team (3)

Name Title Board
Seat
Contact
Info
Anil Shrikhande Chief Executive Officer & Board Member
Gavin Chandler Chief Financial Officer & Board Member
Joseph Blattman Ph.D Founder & Chief Scientific Officer

Gemneo Bioscience Board Members (2)

Name Representing Role Since Contact
Info
Anil Shrikhande Gemneo Bioscience Chief Executive Officer & Board Member 000 0000
Gavin Chandler Gemneo Bioscience Chief Financial Officer & Board Member 000 0000